Annual CFF
$21.05 B
+$25.09 B+621.38%
31 December 2023
Summary:
Amgen annual cash flow from financing activities is currently $21.05 billion, with the most recent change of +$25.09 billion (+621.38%) on 31 December 2023. During the last 3 years, it has risen by +$25.91 billion (+532.46%). AMGN annual CFF is now at all-time high.AMGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$3.65 B
-$1.00 B-37.83%
30 September 2024
Summary:
Amgen quarterly cash flow from financing activities is currently -$3.65 billion, with the most recent change of -$1.00 billion (-37.83%) on 30 September 2024. Over the past year, it has dropped by -$1.65 billion (-82.09%). AMGN quarterly CFF is now -116.97% below its all-time high of $21.51 billion, reached on 31 March 2023.AMGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$5.25 B
-$1.65 B-45.62%
30 September 2024
Summary:
Amgen TTM cash flow from financing activities is currently -$5.25 billion, with the most recent change of -$1.65 billion (-45.62%) on 30 September 2024. Over the past year, it has dropped by -$22.50 billion (-130.47%). AMGN TTM CFF is now -124.96% below its all-time high of $21.05 billion, reached on 31 December 2023.AMGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +621.4% | -82.1% | -130.5% |
| 3 y3 years | +532.5% | -228.2% | +0.9% |
| 5 y5 years | +193.6% | -27.7% | +69.8% |
AMGN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +354.5% | -117.0% | +44.3% | -125.0% | +46.6% |
| 5 y | 5 years | at high | +193.6% | -117.0% | +44.3% | -125.0% | +69.8% |
| alltime | all time | at high | +193.6% | -117.0% | +68.8% | -125.0% | +76.6% |
Amgen Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.65 B(+37.8%) | -$5.25 B(+45.6%) |
| June 2024 | - | -$2.65 B(+55.1%) | -$3.61 B(+66.3%) |
| Mar 2024 | - | -$1.71 B(-162.0%) | -$2.17 B(-110.3%) |
| Dec 2023 | $21.05 B(-621.4%) | $2.75 B(-237.4%) | $21.05 B(+22.1%) |
| Sept 2023 | - | -$2.00 B(+65.7%) | $17.25 B(-17.2%) |
| June 2023 | - | -$1.21 B(-105.6%) | $20.84 B(-0.7%) |
| Mar 2023 | - | $21.51 B(-2150.4%) | $20.99 B(-619.8%) |
| Dec 2022 | -$4.04 B(-51.2%) | -$1.05 B(-166.1%) | -$4.04 B(-57.7%) |
| Sept 2022 | - | $1.59 B(-249.5%) | -$9.55 B(+15.2%) |
| June 2022 | - | -$1.06 B(-69.8%) | -$8.29 B(-15.8%) |
| Mar 2022 | - | -$3.51 B(-46.4%) | -$9.85 B(+19.0%) |
| Dec 2021 | -$8.27 B(+69.9%) | -$6.56 B(-330.3%) | -$8.27 B(+56.0%) |
| Sept 2021 | - | $2.85 B(-208.6%) | -$5.30 B(-46.7%) |
| June 2021 | - | -$2.62 B(+35.2%) | -$9.95 B(+51.8%) |
| Mar 2021 | - | -$1.94 B(-46.0%) | -$6.55 B(+34.6%) |
| Dec 2020 | -$4.87 B(-69.1%) | -$3.59 B(+99.7%) | -$4.87 B(+51.8%) |
| Sept 2020 | - | -$1.80 B(-332.0%) | -$3.21 B(-24.9%) |
| June 2020 | - | $775.00 M(-405.1%) | -$4.27 B(-61.3%) |
| Mar 2020 | - | -$254.00 M(-86.8%) | -$11.03 B(-30.0%) |
| Dec 2019 | -$15.77 B(-29.9%) | -$1.93 B(-32.5%) | -$15.77 B(-9.4%) |
| Sept 2019 | - | -$2.86 B(-52.3%) | -$17.41 B(+1.6%) |
| June 2019 | - | -$5.99 B(+20.2%) | -$17.13 B(+8.5%) |
| Mar 2019 | - | -$4.99 B(+39.8%) | -$15.79 B(-29.8%) |
| Dec 2018 | -$22.49 B(+241.1%) | -$3.57 B(+38.3%) | -$22.49 B(+6.8%) |
| Sept 2018 | - | -$2.58 B(-44.5%) | -$21.06 B(+7.5%) |
| June 2018 | - | -$4.65 B(-60.2%) | -$19.58 B(+21.1%) |
| Mar 2018 | - | -$11.69 B(+447.9%) | -$16.18 B(+145.3%) |
| Dec 2017 | -$6.59 B(+153.7%) | -$2.13 B(+92.8%) | -$6.59 B(+0.2%) |
| Sept 2017 | - | -$1.11 B(-10.9%) | -$6.58 B(+34.5%) |
| June 2017 | - | -$1.24 B(-41.2%) | -$4.89 B(-17.6%) |
| Mar 2017 | - | -$2.11 B(-0.5%) | -$5.94 B(+128.4%) |
| Dec 2016 | -$2.60 B(-31.1%) | -$2.12 B(-464.6%) | -$2.60 B(+85.8%) |
| Sept 2016 | - | $582.00 M(-125.5%) | -$1.40 B(-59.3%) |
| June 2016 | - | -$2.29 B(-286.3%) | -$3.44 B(+199.8%) |
| Mar 2016 | - | $1.23 B(-233.1%) | -$1.15 B(-69.6%) |
| Dec 2015 | -$3.77 B(+15.2%) | -$922.00 M(-36.8%) | -$3.77 B(-37.3%) |
| Sept 2015 | - | -$1.46 B(<-9900.0%) | -$6.01 B(+18.7%) |
| June 2015 | - | $6.00 M(-100.4%) | -$5.07 B(+21.3%) |
| Mar 2015 | - | -$1.40 B(-55.8%) | -$4.18 B(+27.6%) |
| Dec 2014 | -$3.27 B(-220.1%) | -$3.16 B(+516.4%) | -$3.27 B(-188.6%) |
| Sept 2014 | - | -$513.00 M(-157.3%) | $3.69 B(-47.2%) |
| June 2014 | - | $896.00 M(-281.0%) | $7.00 B(+20.3%) |
| Mar 2014 | - | -$495.00 M(-113.0%) | $5.82 B(+113.4%) |
| Dec 2013 | $2.73 B(+550.6%) | $3.81 B(+36.6%) | $2.73 B(-212.3%) |
| Sept 2013 | - | $2.79 B(-1084.8%) | -$2.43 B(-36.0%) |
| June 2013 | - | -$283.00 M(-92.1%) | -$3.79 B(+110.5%) |
| Mar 2013 | - | -$3.58 B(+166.1%) | -$1.80 B(-529.8%) |
| Dec 2012 | $419.00 M(-162.2%) | -$1.35 B(-194.6%) | $419.00 M(-87.9%) |
| Sept 2012 | - | $1.42 B(-16.6%) | $3.46 B(-1958.6%) |
| June 2012 | - | $1.71 B(-225.1%) | -$186.00 M(-140.7%) |
| Mar 2012 | - | -$1.36 B(-180.7%) | $457.00 M(-167.8%) |
| Dec 2011 | -$674.00 M(-45.3%) | $1.69 B(-176.2%) | -$674.00 M(-81.0%) |
| Sept 2011 | - | -$2.22 B(-194.4%) | -$3.55 B(+2879.8%) |
| June 2011 | - | $2.35 B(-194.2%) | -$119.00 M(-96.2%) |
| Mar 2011 | - | -$2.50 B(+111.3%) | -$3.15 B(+155.8%) |
| Dec 2010 | -$1.23 B(-39.1%) | -$1.18 B(-197.8%) | -$1.23 B(-44.7%) |
| Sept 2010 | - | $1.21 B(-276.9%) | -$2.23 B(-34.1%) |
| June 2010 | - | -$683.00 M(+18.6%) | -$3.38 B(+29.8%) |
| Mar 2010 | - | -$576.00 M(-73.5%) | -$2.60 B(+28.7%) |
| Dec 2009 | -$2.02 B(-34.1%) | -$2.18 B(-4058.2%) | -$2.02 B(+40.1%) |
| Sept 2009 | - | $55.00 M(-40.9%) | -$1.45 B(+0.7%) |
| June 2009 | - | $93.00 M(+1760.0%) | -$1.44 B(-53.5%) |
| Mar 2009 | - | $5.00 M(-100.3%) | -$3.09 B(+0.5%) |
| Dec 2008 | -$3.07 B(+15.2%) | -$1.60 B(-2558.5%) | -$3.07 B(+83.7%) |
| Sept 2008 | - | $65.00 M(-104.2%) | -$1.67 B(-2.1%) |
| June 2008 | - | -$1.56 B(-7533.3%) | -$1.71 B(+179.7%) |
| Mar 2008 | - | $21.00 M(-110.6%) | -$611.00 M(-77.1%) |
| Dec 2007 | -$2.67 B(+227.4%) | -$198.00 M(-782.8%) | -$2.67 B(+6.0%) |
| Sept 2007 | - | $29.00 M(-106.3%) | -$2.52 B(-12.8%) |
| June 2007 | - | -$463.00 M(-77.3%) | -$2.89 B(-23.5%) |
| Mar 2007 | - | -$2.04 B(+4141.7%) | -$3.77 B(+363.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | -$815.00 M(-82.0%) | -$48.00 M(-86.0%) | -$815.00 M(-55.8%) |
| Sept 2006 | - | -$342.00 M(-74.6%) | -$1.84 B(+14.3%) |
| June 2006 | - | -$1.35 B(-246.0%) | -$1.61 B(+83.0%) |
| Mar 2006 | - | $924.00 M(-185.7%) | -$882.00 M(-80.6%) |
| Dec 2005 | -$4.54 B(+182.0%) | -$1.08 B(+871.2%) | -$4.54 B(+95.9%) |
| Sept 2005 | - | -$111.00 M(-82.0%) | -$2.32 B(-33.8%) |
| June 2005 | - | -$617.00 M(-77.4%) | -$3.50 B(-7.8%) |
| Mar 2005 | - | -$2.73 B(-339.0%) | -$3.80 B(+136.0%) |
| Dec 2004 | -$1.61 B(+17.3%) | $1.14 B(-188.2%) | -$1.61 B(-50.6%) |
| Sept 2004 | - | -$1.30 B(+42.1%) | -$3.26 B(+51.6%) |
| June 2004 | - | -$912.00 M(+67.6%) | -$2.15 B(+42.8%) |
| Mar 2004 | - | -$544.00 M(+7.3%) | -$1.51 B(+9.7%) |
| Dec 2003 | -$1.37 B(-177.2%) | -$507.00 M(+170.8%) | -$1.37 B(+70.3%) |
| Sept 2003 | - | -$187.20 M(-30.0%) | -$805.50 M(+60.1%) |
| June 2003 | - | -$267.50 M(-34.8%) | -$503.10 M(-33.2%) |
| Mar 2003 | - | -$410.30 M(-789.6%) | -$753.00 M(-142.4%) |
| Dec 2002 | $1.78 B(-472.0%) | $59.50 M(-48.4%) | $1.78 B(+14.3%) |
| Sept 2002 | - | $115.20 M(-122.3%) | $1.56 B(+32.4%) |
| June 2002 | - | -$517.40 M(-124.4%) | $1.17 B(-28.8%) |
| Mar 2002 | - | $2.12 B(-1397.9%) | $1.65 B(-445.2%) |
| Dec 2001 | -$478.00 M(-4.9%) | -$163.40 M(-38.5%) | -$478.00 M(+17.2%) |
| Sept 2001 | - | -$265.50 M(+536.7%) | -$407.80 M(+6.5%) |
| June 2001 | - | -$41.70 M(+463.5%) | -$382.80 M(-19.0%) |
| Mar 2001 | - | -$7.40 M(-92.1%) | -$472.80 M(-5.9%) |
| Dec 2000 | -$502.70 M(-26.3%) | -$93.20 M(-61.2%) | -$502.70 M(-26.7%) |
| Sept 2000 | - | -$240.50 M(+82.6%) | -$685.50 M(+26.1%) |
| June 2000 | - | -$131.70 M(+253.1%) | -$543.60 M(-15.7%) |
| Mar 2000 | - | -$37.30 M(-86.5%) | -$645.10 M(-5.4%) |
| Dec 1999 | -$682.00 M(+68.1%) | -$276.00 M(+179.9%) | -$682.00 M(+51.4%) |
| Sept 1999 | - | -$98.60 M(-57.7%) | -$450.40 M(+3.4%) |
| June 1999 | - | -$233.20 M(+214.3%) | -$435.70 M(+139.8%) |
| Mar 1999 | - | -$74.20 M(+67.1%) | -$181.70 M(-55.2%) |
| Dec 1998 | -$405.80 M(-23.6%) | -$44.40 M(-47.1%) | -$405.80 M(-26.4%) |
| Sept 1998 | - | -$83.90 M(-503.4%) | -$551.60 M(-19.0%) |
| June 1998 | - | $20.80 M(-107.0%) | -$681.00 M(+1.6%) |
| Mar 1998 | - | -$298.30 M(+56.8%) | -$670.30 M(+26.3%) |
| Dec 1997 | -$530.90 M(+29.6%) | -$190.20 M(-10.8%) | -$530.90 M(+35.3%) |
| Sept 1997 | - | -$213.30 M(-777.1%) | -$392.30 M(+46.7%) |
| June 1997 | - | $31.50 M(-119.8%) | -$267.50 M(-36.8%) |
| Mar 1997 | - | -$158.90 M(+207.9%) | -$423.20 M(+3.3%) |
| Dec 1996 | -$409.80 M(+83.2%) | -$51.60 M(-41.7%) | -$409.80 M(-8.7%) |
| Sept 1996 | - | -$88.50 M(-28.7%) | -$448.90 M(+30.8%) |
| June 1996 | - | -$124.20 M(-14.6%) | -$343.30 M(+10.7%) |
| Mar 1996 | - | -$145.50 M(+60.4%) | -$310.20 M(+38.7%) |
| Dec 1995 | -$223.70 M(-13.3%) | -$90.70 M(-630.4%) | -$223.70 M(+14.2%) |
| Sept 1995 | - | $17.10 M(-118.8%) | -$195.80 M(-30.0%) |
| June 1995 | - | -$91.10 M(+54.4%) | -$279.60 M(+14.7%) |
| Mar 1995 | - | -$59.00 M(-6.1%) | -$243.80 M(-5.5%) |
| Dec 1994 | -$258.10 M(+3810.6%) | -$62.80 M(-5.8%) | -$258.10 M(+38.7%) |
| Sept 1994 | - | -$66.70 M(+20.6%) | -$186.10 M(+92.3%) |
| June 1994 | - | -$55.30 M(-24.6%) | -$96.80 M(+261.2%) |
| Mar 1994 | - | -$73.30 M(-896.7%) | -$26.80 M(+306.1%) |
| Dec 1993 | -$6.60 M(-105.3%) | $9.20 M(-59.3%) | -$6.60 M(+10.0%) |
| Sept 1993 | - | $22.60 M(+53.7%) | -$6.00 M(-287.5%) |
| June 1993 | - | $14.70 M(-127.7%) | $3.20 M(-150.8%) |
| Mar 1993 | - | -$53.10 M(-641.8%) | -$6.30 M(-105.0%) |
| Dec 1992 | $125.00 M(+24.3%) | $9.80 M(-69.2%) | $125.00 M(+8.5%) |
| Sept 1992 | - | $31.80 M(+511.5%) | $115.20 M(+38.1%) |
| June 1992 | - | $5.20 M(-93.4%) | $83.40 M(+6.6%) |
| Mar 1992 | - | $78.20 M(+414.5%) | $78.20 M(-37.4%) |
| Dec 1991 | $100.60 M(-19.5%) | - | - |
| Mar 1991 | - | $15.20 M(-78.2%) | $124.90 M(+12.0%) |
| Mar 1991 | $124.90 M(+201.0%) | - | - |
| Dec 1990 | - | $69.80 M(+167.4%) | $111.50 M(+156.9%) |
| Sept 1990 | - | $26.10 M(+89.1%) | $43.40 M(+404.7%) |
| June 1990 | - | $13.80 M(+666.7%) | $8.60 M(-79.3%) |
| Mar 1990 | $41.50 M(+105.4%) | $1.80 M(+5.9%) | $41.50 M(+4.5%) |
| Dec 1989 | - | $1.70 M(-119.5%) | $39.70 M(+4.5%) |
| Sept 1989 | - | -$8.70 M(-118.6%) | $38.00 M(-18.6%) |
| June 1989 | - | $46.70 M | $46.70 M |
| Mar 1989 | $20.20 M | - | - |
FAQ
- What is Amgen annual cash flow from financing activities?
- What is the all time high annual CFF for Amgen?
- What is Amgen annual CFF year-on-year change?
- What is Amgen quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amgen?
- What is Amgen quarterly CFF year-on-year change?
- What is Amgen TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amgen?
- What is Amgen TTM CFF year-on-year change?
What is Amgen annual cash flow from financing activities?
The current annual CFF of AMGN is $21.05 B
What is the all time high annual CFF for Amgen?
Amgen all-time high annual cash flow from financing activities is $21.05 B
What is Amgen annual CFF year-on-year change?
Over the past year, AMGN annual cash flow from financing activities has changed by +$25.09 B (+621.38%)
What is Amgen quarterly cash flow from financing activities?
The current quarterly CFF of AMGN is -$3.65 B
What is the all time high quarterly CFF for Amgen?
Amgen all-time high quarterly cash flow from financing activities is $21.51 B
What is Amgen quarterly CFF year-on-year change?
Over the past year, AMGN quarterly cash flow from financing activities has changed by -$1.65 B (-82.09%)
What is Amgen TTM cash flow from financing activities?
The current TTM CFF of AMGN is -$5.25 B
What is the all time high TTM CFF for Amgen?
Amgen all-time high TTM cash flow from financing activities is $21.05 B
What is Amgen TTM CFF year-on-year change?
Over the past year, AMGN TTM cash flow from financing activities has changed by -$22.50 B (-130.47%)